Sirolimus in Treating Patients With Glioblastoma Multiforme
Status:
Completed
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Chemotherapy drugs such as sirolimus use different ways to stop tumor cells from
dividing so they stop growing or die. Giving a chemotherapy drug before surgery may shrink
the tumor so that it can be removed during surgery.
PURPOSE: Phase I/II trial to study the effectiveness of sirolimus in treating patients who
have glioblastoma multiforme that did not respond to previous radiation therapy.